ACTELION N (ATLN.VX)
-VTX 58.80 
0.20(0.34%) May 17, 11:30AM EDT
| Prev Close: | 59.00 |
|---|
| Open: | 58.70 |
|---|
| Bid: | 58.75 |
|---|
| Ask: | 58.80 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 58.45 - 59.05 |
|---|
| 52wk Range: | 35.71 - 59.95 |
|---|
| Volume: | 707,782 |
|---|
| Avg Vol (3m): | 86,837 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CHF.
Headlines
- Additional macitentan (Opsumit) data in pulmonary arterial hypertension presented at ATSThomson Reuters ONE(Fri, May 17)
- Swiss Stocks Rise, Extending Five-Year High; Adecco Gainsat Bloomberg(Wed, May 15)
- Swiss Stocks Are Little Changed as Actelion Advancesat Bloomberg(Tue, May 14)
- Stocks in Switzerland Advance, Extending Five-Year Highat Bloomberg(Wed, May 8)
- Actelion gets go-ahead to continue new drug trialat Reuters(Wed, May 8)
- Actelion provides update on Phase III GRIPHON study with selexipag in pulmonary arterial hypertension - Study continuesThomson Reuters ONE(Wed, May 8)
- Most Stocks in Switzerland Decline as Actelion Fallsat Bloomberg(Mon, May 6)
- Switzerland Shorn of Bankers Proves Industrial Juggernautat Bloomberg(Sun, Apr 28)
- [$$] Actelion Shareholders Reject Executive Pay Planat The Wall Street Journal(Thu, Apr 18)
- UPDATE 1-Actelion shareholders reject biotech firm's pay plansat Reuters(Thu, Apr 18)
- Actelion's Annual General Meeting of Shareholders held in Basel, SwitzerlandThomson Reuters ONE(Thu, Apr 18)
- Actelion shareholders reject biotech firm's pay plansat Reuters(Thu, Apr 18)
- Q1 2013 Actelion Ltd Earnings Release - 01:00 am ETCCBN(Tue, Apr 16)
- UPDATE 2-Actelion flags possible early return to profit growthat Reuters(Tue, Apr 16)
- Swiss Stocks Retreat for Third Day; Givaudan Shares Fallat Bloomberg(Tue, Apr 16)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
No business summary available forATLN.VX.